Asthma Care With Alvesco® (Ciclesonide) in Primary Care in Adults - The ACCEPT-study (BY9010/CA-102)
Status:
Completed
Trial end date:
2008-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to investigate the effectiveness of Alvesco® (Ciclesonide)
compared with usual asthma care in the primary care setting. Patients with a history of
asthma for at least 6 months and who, in the opinion of the physician, meet the clinical
requirements for treatment with inhaled steroids (ICS) will be enrolled. They will either
receive Alvesco® or usual care.